Tuesday, September 15, 2026

LE SSERAFIM Unveils New Single “Made My Night”: What to Expect from Their Latest Release?

LE SSERAFIM's new song title has been revealed, generating excitement among fans and the music community.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

ASEAN Meeting: What the U.S., South Korea, and Japan Discussed on North Korea and South China Sea

South Korea, the U.S., and Japan reaffirmed their commitment to denuclearization and cooperation during ASEAN-related talks in Manila.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

GC Biopharma Leads Innovation in Cancer Treatment with AI-Powered mRNA Platform

Moderna's recent success in personalized cancer vaccine trials highlights the growing interest in mRNA technology.

Daewoong Pharmaceutical Wins Seoul Biohealth Award: How Open Innovation is Transforming R&D in 2026

Daewoong Pharmaceutical received recognition for its R&D and open innovation collaboration at the 1st Seoul Biohealth Awards.

How Puppy Videos Help Manage Blood Pressure: A Groundbreaking Study for Office Workers

Research suggests that dog videos can help manage cardiovascular and mental health in chronically stressed workers by evoking emotional responses.

200 Successful Treatments: How Lu-177 PSMA Therapy is Revolutionizing Prostate Cancer Care in South Korea

The Catholic University Seoul St. Mary's Hospital's Urology Cancer Center achieves 200 cumulative treatments for metastatic prostate cancer.

EverEx’s MORA Solutions: Revolutionizing Musculoskeletal Care with AI in 2026

EverEx, a digital healthcare company, accelerates expansion with strategic investments from domestic pharma and tech firms.

SK Biopharmaceuticals’s Opakalim: Targeting U.S. Launch in 2029—How Effective Is It at Suppressing Seizures?

SK Biopharmaceuticals takes a significant step with its epilepsy drug candidate Opakalim (BHV-7000) as it addresses the Xcopri one-tool challenge.

DaeWoong’s Nabota: The Korean Botox Revolutionizing the Global Aesthetic Market

Botox is often the first treatment that comes to mind for skin wrinkles, but it's actually a brand name for botulinum toxin.

AbClon Secures Japanese Patent for Dual-Antibody Cancer Drug AM105: What This Means for Global Markets

AbClon has completed the registration of a Japanese patent for its next-generation dual antibody immuno-oncology candidate AM105.

CS5001: 100% Complete Response Rate in DLBCL Clinical Trial – A Game Changer for Cancer Treatment?

LigaChem Biosciences reveals clinical data for cancer drug CS5001 targeting DLBCL, developed in partnership with CStone Pharmaceuticals.

CS5001 Breakthrough: 100% Complete Remission in DLBCL Trials – What This Means for Cancer Treatment

ABL Bio's ADC candidate shows complete response in all patients in early trials for first-line treatment of DLBCL.

Deep Neuro BrainSeg: Revolutionizing Brain MRI Analysis for Enhanced Diagnosis in 2026

Deepnoid expands its medical AI solutions by adding automated MRI analysis for brain volume assessment, aiding in brain disease diagnosis.

Unlocking Innovation: How the 2026 KDDF Science Conference is Shaping the Future of Drug Development

Innovation in drug development arises from collaboration among scientists across various fields sharing knowledge and experience.

AI Predicts Dementia Risk From a Single Eye Photo, Korean Researchers Develop Model

Korean researchers have developed an AI model that can screen for current dementia and predict future dementia risk using only retinal fundus photographs.

Discover Daewoong Alliance: How Digital Healthcare is Transforming Patient Care in 2026

Daewoong Pharmaceutical accelerates business expansion by collaborating with domestic digital healthcare firms using medical data and AI.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.